[HTML][HTML] Investigating genes associated with heart failure, atrial fibrillation, and other cardiovascular diseases, and predicting disease using machine learning …

V Venkat, H Abdelhalim, W DeGroat, S Zeeshan… - Genomics, 2023 - Elsevier
Cardiovascular disease (CVD) is the leading cause of mortality and loss of disability
adjusted life years (DALYs) globally. CVDs like Heart Failure (HF) and Atrial Fibrillation (AF) …

Personalized medicine in cardiovascular disease: review of literature

A Sheikhy, A Fallahzadeh, HR Aghaei Meybodi… - Journal of Diabetes & …, 2021 - Springer
Purpose Personalized medicine (PM) is the concept of managing patients based on their
characteristics, including genotypes. In the field of cardiology, advantages of PM could be …

[HTML][HTML] Warfarin therapy and pharmacogenetics: A narrative review of regional and Iraqi studies

AM Abd Alridha, KM Al-Gburi… - Medical Journal of …, 2022 - journals.lww.com
The aim of this work was to review several studies investigating the effects of genetic
polymorphisms on warfarin dosing in regional and Iraqi studies and to report any consistent …

ACE gene polymorphism and susceptibility to hypertension in a Jordanian adult population

L Al-Eitan, S Al-Khaldi, R Ibdah - PLoS One, 2024 - journals.plos.org
Hypertension is one of the most common and complicated disorders associated with genetic
and environmental risk factors. The angiotensin-converting enzyme (ACE) is important in the …

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy

D Huang, F Xie, S Xiao, M Cai, D Hu, B Ling, F Wang… - Scientific Reports, 2024 - nature.com
Warfarin is the most widely used oral anticoagulant in clinical practice. The cytochrome
P450 2C9 (CYP2C9), vitamin K epoxide reductase complex 1 (VKORC1), and cytochrome …

Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients

LN Al-Eitan, AY Almasri, AH Alnaamneh, A Mihyar - Plos one, 2023 - journals.plos.org
Aims This study aims to investigate the influence of MEF2A and SLC22A3-LPAL2-LPA
polymorphisms on cardiovascular disease susceptibility and responsiveness to warfarin …

PTPRD gene variant rs10739150: A potential game-changer in hypertension diagnosis

L Al-Eitan - Plos one, 2024 - journals.plos.org
Background High blood pressure, also known as hypertension (HTN), is a complicated
disorder that is controlled by a complex network of physiological processes. Untreated …

Coronary artery disease, its associations with ocular, genetic and blood lipid parameters

I Matulevičiūtė, V Tatarūnas, V Skipskis, I Čiapienė… - Eye, 2024 - nature.com
Background/objectives To investigate the associations between ophthalmic parameters,
CYP4F2 (rs2108622) and ABCA1 (rs1883025) polymorphisms and coronary artery disease …

Drug Metabolizing Enzymes: An Exclusive Guide into Latest Research in Pharmaco-genetic Dynamics in Arab Countries

LAL Eitan, IY Khair, S Alahmad - Current Drug Metabolism, 2024 - benthamdirect.com
Drug metabolizing enzymes play a crucial role in the pharmacokinetics and
pharmacodynamics of therapeutic drugs, influencing their efficacy and safety. This review …

[PDF][PDF] Kajian Sediaan Orally Dissolving Film (ODF)

MS Ramadhan, UA Lantika - Jurnal Riset Farmasi, 2022 - scholar.archive.org
Oral route administration is the most common route and most widely known. However, this
route is not always given beneficial. Some of the problems commonly encountered in this …